Inhibitory action of the adenine analog, 4-aminopyrazolo(3,4-d)pyrimidine, in Crithidia fasciculata.
The adenine analog 4-aminopyrazolo(3,4-d)pyrimidine inhibits the growth of the kinetoplastid (trypanosomatid) flagellate Crithidia fasciculata. This inhibition is partially overcome only by adenine (of a number of purines tested), with an inhibition index of 0.025. More effective reversal of inhibition is obtained with any of a number of naturally occurring pyrimidine compounds, up to a concentration of 0.18 mM. Higher concentrations of pyrimidines or addition of guanine, as well as adenine and uracil, to the medium increases inhibition. The analog (presumably as the ribonucleotide) was found not to be inhibitory to any enzyme of the pyrimidine biosynthetic pathway that could be tested. It is suggested that the analog competes with adenine for adenine phosphoribosyltransferase (AMP:pyrophosphate phosphoribosyltransferase, EC 2.4.2.7), is converted to a ribonucleotide, and is incorporated into nucleic acid.
D000225:Adenine / Q000031:analogs & derivatives* / Q000494:pharmacology; D000228:Adenine Phosphoribosyltransferase / Q000378:metabolism; D000818:Animals; D004305:Dose-Response Relationship, Drug; D056890:Eukaryota / Q000187:drug effects / Q000201:enzymology / Q000254:growth & development*
C004420:4-aminopyrazolo(3,4-d)pyrimidine; D000228:Adenine Phosphoribosyltransferase; D000225:Adenine